Your browser doesn't support javascript.
loading
Prevention of acute and delayed chemotherapy-induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline.
Patel, Priya; Robinson, Paula D; Cohen, Marie; Devine, Katie; Gibson, Paul; Holdsworth, Mark T; Neumann, Eloise; Orsey, Andrea; Phillips, Robert; Spinelli, Daniela; Thackray, Jennifer; van de Wetering, Marianne; Woods, Deborah; Cabral, Sandra; Sung, Lillian; Dupuis, L Lee.
Afiliação
  • Patel P; Pediatric Oncology Group of Ontario, Toronto, Canada.
  • Robinson PD; Department of Pharmacy, The Hospital for Sick Children, Toronto, Canada.
  • Cohen M; Pediatric Oncology Group of Ontario, Toronto, Canada.
  • Devine K; Not applicable (patient representative).
  • Gibson P; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
  • Holdsworth MT; Pediatric Oncology Group of Ontario, Toronto, Canada.
  • Neumann E; Division of Haematology/Oncology, McMaster Children's Hospital, Hamilton, Canada.
  • Orsey A; College of Pharmacy, University of New Mexico, Albuquerque, New Mexico, USA.
  • Phillips R; Birmingham Women's and Children's Hospital, Birmingham, UK.
  • Spinelli D; Division of Pediatric Hematology/Oncology, Connecticut Children's Medical Center, Hartford, Connecticut, USA.
  • Thackray J; Department of Pediatrics, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
  • van de Wetering M; Department of Haematology and Oncology, Leeds Teaching Hospital, NHS Trust, Leeds, UK.
  • Woods D; Not applicable (patient representative).
  • Cabral S; Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Sung L; Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Dupuis LL; University of California, Davis Health, Pediatric Hematology/Oncology, Davis, California, USA.
Pediatr Blood Cancer ; 69(12): e30001, 2022 12.
Article em En | MEDLINE | ID: mdl-36221901
ABSTRACT
This clinical practice guideline provides recommendations for preventing acute and delayed phase chemotherapy-induced nausea and vomiting (CINV) in pediatric patients. The recommendations are based on two systematic reviews of randomized controlled trials evaluating interventions to prevent (1) acute phase CINV and (2) delayed phase CINV. Recommendations for acute phase and delayed phase CINV prophylaxis are made for patients receiving chemotherapy of varying emetogenicity, as well as for patients not able to receive dexamethasone or a neurokinin-1 receptor antagonist. Evidence gaps, including antiemetic safety and optimal dosing, were identified.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antieméticos / Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Systematic_reviews Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antieméticos / Neoplasias / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Systematic_reviews Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article